Esoteric Testing Market Quality & Quantity Analysis | Labcorp, Quest Diagnostics & OPKO Health Inc

Esoteric Testing Market

This study on Esoteric Testing Market involved four major activities in estimating the current size of the esoteric testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Major Growth Drivers:

The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The objective of the report is to define, describe, and forecast the esoteric testing market size based on type, technology, laboratory type, and regions.

Expected Revenue Growth:

[223 Pages Report] The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.

The global esoteric testing market is consolidated. The prominent players operating in this market include Labcorp (US), Quest Diagnostics (US) and OPKO Health Inc. (US).

Labcorp (US)

Labcorp (US) is one of the leading players in the esoteric testing market. Labcorp Diagnostics (Dx) is the diagnostic business segment of the company that operates through a network of rapid response laboratories, specialty laboratories, primary laboratories, patient service centers, and branches. The company has a strong presence in the North America, Europe, and others. The company has a strong position in commercializing new diagnostic technologies and delivering a combination of world-class diagnostics, drug development, and knowledge services.

Recent Developments

  • Labcorp will acquire Myriad Genetics’ autoimmune business unit.
  • Quest Diagnostics collaborated with GRAIL to support a first-of-its-kind multi-cancer early detection blood test called Galleri.
  • OPKO Health Inc. (BioReference Laboratories) launched Scarlet Health, an in-home diagnostic, fully integrated digital platform, in the US.
  • H.U. Group Holdings’ subsidiary, Miraca Holdings, partnered with the Chugai Pharmaceutical Co., Ltd.

Frequently Asked Questions (FAQ):

  1. What is the impact of COVID-19 on the esoteric testing market?
  2. Who are the key players in the esoteric testing market?
  3. Which type of esoteric test dominates in the esoteric testing market?
  4. What factors are driving the esoteric testing market?
  5. What is the market for global esoteric testing services?

Make an Enquire to buy this Report @